Figure 4
Figure 4. B220+CD19− adherent cells from differentiated LSK cells cultured on OBs in vitro differentiate into IgM+ B cells in vivo. LSK cells from CD45.1+ mice were cultured on (CD45.2+) OB monolayers for 10 days, and the OB-adherent hematopoietic cells (OB-adh) were recovered. B220+CD19− pre-pro-B cells were isolated by FACS and transplanted into sublethally irradiated CD45.2 mice. (A) CD45.1+ cell contributions to recipient bone marrow, spleen, thymus, and blood after 21 days (means ± SD, n = 5). (B) Costaining with CD45.1 and B-cell differentiation markers, demonstrating the presence of donor-derived CD45.1+B220+CD19+IgM+ immature B lymphocytes in BM and spleen (n = 5). (C) Phenotypic characterization of (CD45.1+) donor-derived B220−CD19− cells in recipient (CD45.2+) bone marrow.

B220+CD19 adherent cells from differentiated LSK cells cultured on OBs in vitro differentiate into IgM+ B cells in vivo. LSK cells from CD45.1+ mice were cultured on (CD45.2+) OB monolayers for 10 days, and the OB-adherent hematopoietic cells (OB-adh) were recovered. B220+CD19 pre-pro-B cells were isolated by FACS and transplanted into sublethally irradiated CD45.2 mice. (A) CD45.1+ cell contributions to recipient bone marrow, spleen, thymus, and blood after 21 days (means ± SD, n = 5). (B) Costaining with CD45.1 and B-cell differentiation markers, demonstrating the presence of donor-derived CD45.1+B220+CD19+IgM+ immature B lymphocytes in BM and spleen (n = 5). (C) Phenotypic characterization of (CD45.1+) donor-derived B220CD19 cells in recipient (CD45.2+) bone marrow.

Close Modal

or Create an Account

Close Modal
Close Modal